NovoCure Ltd Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 53.10 | 1,900 | 100,881 | 894,563 | 896.5 K to 894.6 K (-0.21 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Option Exercise | M | 12.30 | 23,600 | 290,280 | 0 | |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Option Exercise | M | 11.39 | 21,500 | 244,885 | 0 | |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Option Exercise | M | 6.72 | 50,000 | 336,000 | 62,607 | |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Sell | S | 52.82 | 1,400 | 73,949 | 9,504 | 10.9 K to 9.5 K (-12.84 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Sell | S | 52.08 | 22,200 | 1,156,265 | 10,904 | 33.1 K to 10.9 K (-67.06 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Buy | M | 12.30 | 23,600 | 290,280 | 33,104 | 9.5 K to 33.1 K (+248.32 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Sell | S | 52.96 | 5,174 | 274,020 | 9,504 | 14.7 K to 9.5 K (-35.25 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Sell | S | 52.09 | 16,326 | 850,356 | 14,678 | 31 K to 14.7 K (-52.66 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Buy | M | 11.39 | 21,500 | 244,885 | 31,004 | 9.5 K to 31 K (+226.22 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Sell | S | 52.84 | 2,920 | 154,304 | 9,504 | 12.4 K to 9.5 K (-23.50 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Sell | S | 52.09 | 47,080 | 2,452,303 | 12,424 | 59.5 K to 12.4 K (-79.12 %) |
| May 31 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Buy | M | 6.72 | 50,000 | 336,000 | 59,504 | 9.5 K to 59.5 K (+526.09 %) |
| May 24 2019 | NVCR | NovoCure Ltd | HILLEMAN JERYL L | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | HILLEMAN JERYL L | Director | Grant | A | 0.00 | 3,359 | 0 | 3,359 | 0 to 3.4 K |
| May 24 2019 | NVCR | NovoCure Ltd | McCoy Sherilyn S | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | McCoy Sherilyn S | Director | Grant | A | 0.00 | 3,359 | 0 | 3,359 | 0 to 3.4 K |
| May 24 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Grant | A | 0.00 | 3,359 | 0 | 69,504 | 66.1 K to 69.5 K (+5.08 %) |
| May 24 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Grant | A | 0.00 | 3,359 | 0 | 258,589 | 255.2 K to 258.6 K (+1.32 %) |
| May 24 2019 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Grant | A | 0.00 | 3,359 | 0 | 12,265 | 8.9 K to 12.3 K (+37.72 %) |
| May 22 2019 | NVCR | NovoCure Ltd | Burkoth William T. | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | Burkoth William T. | Director | Buy | M | 48.87 | 6,145 | 300,306 | 6,145 | 0 to 6.1 K |
| May 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 48.87 | 6,145 | 300,306 | 66,145 | 60 K to 66.1 K (+10.24 %) |
| May 22 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Buy | M | 48.87 | 6,145 | 300,306 | 255,230 | 249.1 K to 255.2 K (+2.47 %) |
| May 22 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Buy | M | 48.87 | 6,145 | 300,306 | 6,145 | 0 to 6.1 K |
| May 22 2019 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Option Exercise | M | 0.00 | 8,906 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Buy | M | 48.87 | 8,906 | 435,236 | 8,906 | 0 to 8.9 K |
| May 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 59,743 | |
| May 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 49.79 | 5,000 | 248,950 | 60,000 | 65 K to 60 K (-7.69 %) |
| May 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 65,000 | 60 K to 65 K (+8.33 %) |
| May 10 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 47.56 | 20,000 | 951,200 | 20,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 47.56 | 33,052 | 1,571,953 | 33,052 | |
| May 10 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.56 | 20,000 | 951,200 | 20,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.56 | 36,650 | 1,743,074 | 36,650 | |
| May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | A | 47.56 | 35,000 | 1,664,600 | 35,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | A | 47.56 | 115,060 | 5,472,254 | 115,060 | |
| May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.37 | 31,460 | 1,490,386 | 896,463 | 927.9 K to 896.5 K (-3.39 %) |
| May 10 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | A | 47.56 | 20,000 | 951,200 | 20,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | A | 47.56 | 91,515 | 4,352,453 | 91,515 | |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 293,839 | |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 352,607 | |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 47.62 | 58,768 | 2,798,532 | 927,923 | 869.2 K to 927.9 K (+6.76 %) |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.52 | 32,218 | 1,531,032 | 869,155 | 901.4 K to 869.2 K (-3.57 %) |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 48.92 | 58,768 | 2,874,931 | 901,373 | 842.6 K to 901.4 K (+6.97 %) |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.67 | 32,098 | 1,530,112 | 842,605 | 874.7 K to 842.6 K (-3.67 %) |
| May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 411,375 | |
| May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 48.89 | 58,768 | 2,873,168 | 874,703 | 815.9 K to 874.7 K (+7.20 %) |
| May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 48.07 | 29,038 | 1,395,915 | 815,935 | 845 K to 815.9 K (-3.44 %) |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 470,143 | |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 528,911 | |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 44.60 | 58,768 | 2,621,053 | 844,973 | 786.2 K to 845 K (+7.47 %) |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 45.21 | 29,966 | 1,354,643 | 786,205 | 816.2 K to 786.2 K (-3.67 %) |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 43.28 | 58,768 | 2,543,479 | 816,171 | 757.4 K to 816.2 K (+7.76 %) |